Defining the pathway of biomarkers for pharmacodynamics, efficacy and toxicity for 11B-HSD1 inhibition in metabolic disease indications

Walker, Brian (Principal Investigator)
Andrew, Ruth (Co-investigator)
Critchley, Hilary (Co-investigator)
Jansen, Maurits (Co-investigator)
Reynolds, Rebecca (Co-investigator)
Seckl, Jonathan (Co-investigator)

Status	Finished
Effective start/end date	1/04/07 → 30/06/12

Funding

UK industry, commerce and public corporations: £1,112,195.00

1 Article

Glucocorticoids Turn Over Slowly in Human Adipose Tissue in Vivo
Hughes, K. A., Reynolds, R. M., Andrew, R., Critchley, H. O. D. & Walker, B. R., Oct 2010, In: Journal of Clinical Endocrinology & Metabolism. 95, 10, p. 4696-4702 7 p.
Research output: Contribution to journal › Article › peer-review